Idarucizumab for a traumatic head injury patient taking dabigatran

ConclusionWe managed a patient taking dabigatran who suffered traumatic intracranial hemorrhage by administering idarucizumab preoperatively without the need for blood transfusion perioperatively. We suggest that idarucizumab could be a potent therapeutic bridge to definitive surgical management in such patients with traumatic brain injury who are taking dabigatran.
Source: International Journal of Emergency Medicine - Category: Emergency Medicine Source Type: research